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Scrapie, the prototype of a group of diseases designated as transmissible
spongiform encephalopathies (TSEs) or prion diseases, is a naturally
occurring affliction of sheep which was recognized more than 250
years ago. Characteristically, affected animals present with twitching,
excitability, intense itching and finally paralysis and death. Transmis-
sion of the disease by inoculation of healthy sheep and goats with
lumbar cord of diseased animals was first demonstrated in 19361 and
soon confirmed by Gordon.2 This led to the recognition of the unusual
properties of the pathogenic agent (later designated as 'prion'3, such as
the extremely long incubation periods, exceeding 1 year, and resistance
to high temperatures, formaldehyde treatment and UV irradiation.2-4-5
In a separate development, Creutzfeld-Jakob disease (CJD),
Gerstmann-Straussler-Scheinker disease (GSS) and kuru were charac-
terized as slow degenerative diseases of the central nervous system. The
suggestion by Hadlow6 that these diseases might be the counterpart of
scrapie in humans was followed by long-term inoculation studies by
Gajdusek and his colleagues which resulted in the transmission, first of
kuru7, then of CJD8 to chimpanzees. Later, GSS was also transmitted to
the chimpanzee9 and to the mouse.10 Recently we have witnessed the
emergence of a new form of a prion disease, namely bovine spongiform
encephalopathy (BSE), which is attributed to the feeding of cattle with
meat and bone meal supplements derived from scrapie-contaminated
sheep and then cattle offal.11-12
The overall properties of the prion differ from those of any known
virus or viroid2-4>13 and early on gave rise to speculations that it
might be devoid of both nucleic acid and protein,14 consist of protein
only15"17 or be a polysaccharide17a or a membrane fragment.18 In this
article we review the current hypotheses regarding the pathogenesis of
Note added in proof: Unheated brain extracts of PrP<M> mice 25, 33 and 48 weeks after
inoculation with scrapie prions show no scrapie infectivity. Thus, the positive result for
the 20-week PrP<>/0 mouse (Table) is likely accidental.
9 9 6 ROLE OF PrP DM PRION DISEASES
this class of diseases (for recent reviews, see Refs 19-24), in particular
the so-called 'protein only' hypothesis and the major lines of evidence
in its support, and describe experiments carried out in our laboratory
demonstrating the essential role of the host gene Prn-p in the patho-
genesis of scrapie.25
THE 'PROTEIN ONLY' HYPOTHESIS
Prusiner has suggested that the prion is devoid of nucleic acid and
identical with PrPSc, a modified form of PrPC (the 'protein only'
hypothesis).26 PrPC is a normal host protein27"29 encoded within a
single exon of a single copy gene30 and is found predominantly on
the outer surface of neurons, attached by a glycosyl phosphatidyl in-
ositol anchor19'26-31-32 but also in a variety of other tissues, both in the
embryonic and the adult mouse.33-34
PrPSc is denned as a largely protease-resistant form of PrPC
which readily forms aggregates after treatment with detergents
and protease.27- 35-37 jt accumulates intracellularly, in cytoplasmic
vesicles38-39 and is the major component of the extracellular amyloid
plaques characteristic for some forms of prion diseases. No chemical
differences have so far been detected between PrPSc and PrPCl9,40,4l;
however, it must be stressed that the ratio of infectious units to PrPSc
molecules is in the order of 1:100 000,42 so that if the infectious entity
were a subspecies of PrPSc or a different modification of PrP altogether
a chemical difference between PrPC and the infectious subspecies could
be analytically undetectable.
Prusiner proposed that PrPSc, when introduced into a normal cell,
causes the conversion of Prpc or its precursor into PrPSc 19,27,43,45^6
(Fig. 1A). The nature of the conversion is unknown and could be due to
a chemical or conformational modification, during or after its synthesis.
However, the existence of many different strains of scrapie which can
be propagated in one and the same inbred mouse line, and the apparent
mutability of the agent21-23 are cited in support of the virino hypothesis
(Fig. IB), which holds that the infectious agent consists of a nucleic
acid genome and the host-derived PrP, which is recruited as some sort
of coat.27-48 No credible evidence for such a nucleic acid has yet been
forthcoming.22.43'44.48 Finally, the possibility that the infectious agent
is a virus with unusual properties is still upheld by some.24-49
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Fig. 1 Models for the propagation of the scrapie agent (prion). (A) The 'protein only'
model assumes that the prion is identical with PrPSc. Exogenous PrPSc causes the
conversion of the normal cellular protein PrPC into PrPSc. (B) The 'virino hypothesis'
assumes that the infectious agent consists of a scrapie-specific nucleic acid associated
with or packaged in PrPSc. The 'scrapie specific nucleic acid' (to date never found) is
replicated in the cell and recruits PrPC into association with it. Strain specificity would
be mediated by the nucleic acid.
PREVIOUS EVIDENCE BEARING ON THE RELATIONSHIP OF
PrP TO TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
Scrapie infectivity is associated with PrPSc
Purification of scrapie infectivity results in a preparation highly en-
riched with regard to PrPSc.35,50,51 Conversely, purification of PrPSc
by affinity chromatography on an anti-PrP antibody column leads to
enrichment of infectivity.52
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A nucleic acid larger than about 100 nucleotides is not essential
for infectivity of scrapie prion preparations
This claim is based on: (a) the unusually small target size of scrapie
infectivity for UV and ionizing radiation16-53.54; (b) the low ratio of
nucleic acids to infectious units in highly purified prion preparations44
and the failure to find scrapie-specific nucleic acid in prion prepara-
tions or scrapie-infected brain tissue22.43-55; (c) resistance of infectivity
to treatment with agents modifying or damaging nucleic acids.3 Col-
lectively, these data suggest that a nucleic acid of more than 50-100
nucleotides is not required for infectivity (but see Ref. 56 for a different
conclusion).
The susceptibility of a host to scrapie infection is co-determined
by the prion inoculum and the PrP gene
The significance of the host PrP genotype for the susceptibility to
scrapie infection and the course of the disease is revealed by two
sets of findings. First, the incubation time for one and the same prion
isolate may be different in distinct mouse strains, and is determined
predominantly by Sine51'58 or Prn-i59'60 which is very closely linked
to or coincident with Prn-p, the gene encoding PrP.59"63 Second, when
prions are transmitted from one animal species to another, disease often
develops only after a very long incubation period, if at all. However,
upon serial passaging in the new species, the incubation time may
decrease dramatically and then stabilize. At least in the case of ham-
ster and mouse, this so-called species barrier64 can be overcome by
introducing into the recipient host the PrP transgene from the prion
donor.45-65 Moreover, prion preparations from mice carrying hamster
PrP-transgenes and inoculated with hamster scrapie prions are highly
infectious to the hamster but not to the mouse. The same transgenic
mouse strain, infected with mouse-derived prions, yields preparations
highly infectious for mice but not for hamsters.45 Within the framework
of the 'protein only' hypothesis this means that hamster PrP0, but not
murine PrPC, is a suitable substrate for conversion to hamster PrPSc by
hamster prions and vice versa.
Hereditary forms of spongiform encephalopathies are linked to
mutations of the PrP gene
The human prion diseases, Creutzfeldt-Jakob (CJD) and Gerstmann-
Straussler-Scheinker disease (GSS), are very rare in the overall popula-
tion, but also occur as a familial form.8'9.66-67 Hsiao et al68 found that
in two apparently unrelated GSS families the disease is tightly linked
to a proline-to-leucine change in codon 102 of one of the Prn-p alleles.
Subsequently other GSS and CJD families were identified, carrying the
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102 mutation or one of a number of other mutations in the PrP gene
(for a review see Ref. 69). Prusiner26 proposed that the mutations allow
spontaneous conversion of PrPC into PrPSc with a frequency sufficient
to allow the disease to be expressed within the lifetime of the individual.
Sporadic CJD would be attributable to a somatic mutation in the Prn-p
gene or to rare instances of spontaneous conversion of PrPC into PrPSc
(Fig. 2A).
Hsiao et al.70 showed that mice carrying a murine PrP transgene
with the pro—>leu mutation corresponding to the human GSS mutation
at position 102 spontaneously come down with a lethal scrapie-like
disease. However, it has not yet been reported whether or not the brains
of these animals contain prions.
SUSCEPTIBILITY TO SCRAPIE OF MICE DEVOID OF PrPC
The 'protein only' hypothesis predicts that in the absence of PrPC, mice
should be resistant to scrapie infection, both with regard to symptoms
and to propagation of the infectious agent.
Generation and properties of Prn-p010 mice
Mice devoid of PrP71 were generated by the general approach described
by others.72-75 In short, one Prn-p allele of murine embryonic stem
(ES) cells was disrupted (Fig. 2A) by homologous recombination with
a 4.8 kb DNA fragment in which codons 4-187 of the 254-codon
open reading frame, which is located within a single exon, were re-
placed by a neomycin phosphotransferase (neo) gene under the con-
trol of the HSV TK promoter (Fig. 2B). In the resulting construction
(Fig. 2C) the first 3 Prn-p codons, the neo encoding sequence and
the residual 67 Prn-p codons were fused in frame, with one nonsense
codon interposed between the initial Prn-p codons and the neo sequence
and two nonsense codons between the latter and the residual Prn-p
sequence (Fig. 2D). Thus, the synthesis of PrP or any fragment thereof
is precluded. Blastocysts from black mice were injected with agouti
ES cells carrying the disrupted Prn-p gene and implanted into foster
mothers. Chimeric males (showing agouti patches) were mated with
wild type black mice and agouti offspring carrying the disrupted gene
were identified by PCR analysis. Prn-p°/+ heterozygotes were mated
and 176 superficially indistinguishable offspring analyzed by PCR. Of
these, 24% were homozygous for the disrupted Prn-p gene.
As shown by Northern analysis, normal PrP mRNA was not de-
tectable in brain from Prn-p0/0 homozygotes, however substantial quan-
tities of a fused mRNA containing the neo and the residual Prn-p
sequence were present. Western analysis of brain proteins showed that
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Fig. 2 Construction of the PrP targeting vector. (A) Map of the murine PrP gene.88 (B)
The targeting vector was constructed by replacing 552 bp of the Pm-p coding region
(extending from position 10-562) by a 1.1 kb cassette containing the HSV thymidine
kinase promoter followed by the neo gene. (C) The disrupted PrP gene. (D) The first 3
Pm-p codons, the neo coding sequence and the residual 67 Pm-p codons were fused in
frame, with one nonsense codon interposed between the initial Pm-p codons and the neo
sequence and two nonsense codons between the latter and the residual Pm-p sequence.
PrP was undetectable in Prn-p°/0 samples and present at about half the
normal level in Prn-p°/+ samples.
No gross abnormalities were noted in Prn-pft/0 mice at the macro-
scopic or microscopic level, in particular of the brain, skeletal muscle
and visceral organs.71'76 Disruption of the Prn-p gene had no detectable
effect on the normal maturation of the lymphocyte subsets. No sig-
nificant difference in the response of splenocytes from Prn-p°/0 and
Prn-p+/+ mice to activation by concanavalin A was detected.71
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Because PrPC is a predominantly neuronal protein and present in a
high proportion of hippocampal neurons, the learning ability of Prn-
p°/0, Prn-p+/+ and Prn-p°/+ mice, all derived from the mating of the first
generation of heterozygotes, was compared. Three tests, the swimming
navigation test,77 the Y-maze discrimination test78 and the two-way
avoidance (shuttlebox) test79 revealed no differences between the three
groups of mice.
Homozygous Prn-jfi10 mice are fertile and normal progeny result
from homozygous Prn-p0/0 breeding pairs. No abnormalities of homo-
zygotes were recorded during 18 months of observation. It is surprising
that a protein expressed in many areas of the brain and in other tissues
and whose gene has been found in mammals, birds and fish can be
ablated without apparent detrimental effects. It is possible that its func-
tion is too subtle to be detected under laboratory conditions, or that it
can be replaced by some other gene product(s), particularly if adaptive
processes are facilitated during development.
Challenge of Prn-p0/0 and Pm-p0/+ mice with scrapie prions
Mice devoid of PrP were challenged with mouse prions and proved to
be completely protected against scrapie disease, at least up to 14 months
after inoculation (Fig. 3). Moreover, even heterozygous Prn-p0/+ mice
proved to be partially protected, inasmuch as scrapie-inoculated animals
showed signs of scrapie only 253-337 days after inoculation but are
still alive after 380 days, while all Prn-p+/+ controls died within about
180 days. Moreover, disease progression in Prn-p0/+ mice is distinctly
slower than in Prn-p+/+ mice, the interval between first symptoms and
death being 13 days in the case of Prn-p+/+ mice while no Prn-p0/+
mice have died to date, about 3 months after the appearance of scrapie
symptoms (Biieler and Weissmann, unpublished results).
We conclude that development of scrapie symptoms and pathology
is strictly dependent on the presence of PrP and that incubation time
and disease progression are inversely related to the level of PrP. It has
previously been found that the length of the scrapie incubation time for
hamster-derived prions in mice expressing SHaPrP genes was inversely
related to the level of SHaPrP.45
Are prions propagated in Prn-p0/0 mice?
It was shown that if infectious agent is propagated in Prn-p0/0 mice,
this would be at a level about five orders of magnitude lower than
that in Prn-p+/+ animals.25 Scrapie prion titers were determined by
preparing tissue extracts at various times after inoculation, heating them
for 20 min at 80°C to destroy any adventitious conventional pathogens
and inoculating them into wild type indicator mice. In scrapie-
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Fig. 3 Susceptibility of mice with various PrP genotypes to inoculation with scrapie
prions. Mice were inoculated intracerebrally and the percentage of mice remaining free
of scrapie symptoms was plotted as a function of time. (A) Pm-p®0 and Prn-p+/+ mice
were inoculated with mouse prions. One Pm-p010 mouse (arrow) showed ataxic gait and
was sacrificed at 240 days: it showed no histopathological changes typical for scrapie and
brain homogenate from this mouse did not transmit scrapie to CD-1 indicator mice after
more than 170 days. (B) Prn-pO® and Pra-p^/tgHaPrP mice (Prn-pO/0
 m i c e carrying
Syrian hamster transgenes) were inoculated with hamster scrapie prions.
inoculated Prn-p+/+ animals, infectious agent was detected in the brain
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at 8 weeks and increased to about 8.6 log LD50 units/ml by 20 weeks
after inoculation (Table). No infectious agent was detected in Prn-p0^
animals 25 weeks after inoculation, the latest time point for which data
are presently available. However, in a parallel assay using unheated
samples, a low level of infectivity, about 3.2 log LD50 units/ml, was
found in the 20 week sample from Prn-jfi/0 animals. Because only one
Prn-p°/0 brain sample in the entire experiment was positive, accidental
contamination of the homogenate or infectivity due to residual traces
of inoculum in the occasional mouse cannot be excluded. However, the
possibility must be considered that the infectious agent is something
other than PrPSc, and that in the absence of PrPSc in the host it is much
less infectious than in its presence. This question can only be resolved
by further experiments, which are now underway.
Table Priori titers in brain and spleen of Pm-p+/+ and Prn-p0/0 mice3
Time after
inoculation
4 days
2 weeks
8 weeks
12 weeks
20 weeks
23/25 weeks
Brain (heated)
prp+/+
< 1.5
< 1.5
5.4
6.8
8.6
8.1 ±0.8
prp0/0
2.0b
< 1.5
< 1.5
< 1.5
< 1.5
< 1.5
Brain (not
prp+/+
n.d.
n.d.
7.7 ± 0.6
7.1 ± 1.6
7.7 ± 1.1
n.d.
heated)
prpom
n.d.
n.d.
< 1.5
< 1.5
3.2 ± 1.4<i
n.d.
Spleen
prp+/+
5.7 ± 0.9
6.2 ± 0.8
6.9 ± 1.0
5.9 ± 0.6
6.9 ± 0.6
n.d.
(heated)
PrpO/0
2.3C
< 1.5
< 1.5
< 1.5
< 1.5
< 1.5
aThe samples designated 'heated' were kept 20 min at 80°C prior to inoculation. The
titers of brain homogenates recovered at 8, 12 and 20 weeks after inoculation and of the
Chandler-derived mouse prion inoculum 'RML' (8.5 log LD50 units/ml) were determined
by end point dilution. The titers of the other samples were determined by the incubation
time assay (Ref. 25) b l /6 mice died after inoculation with 10 ' diluted homogenate. c2/6
mice died after inoculation with 10"1 diluted homogenate d6/6 mice died after inoculation
with 10"1 diluted homogenate
Restoration of susceptibility to scrapie by introduction of PrP
transgenes.
When ablation of a gene product gives rise to a specific phenotype,
in this case resistance to scrapie, it is desirable to demonstrate that
reinstatement of the gene restores the original phenotype. Indeed, inser-
tion of mouse PrP genes rendered Prn-p°/0 mice susceptible to mouse
prions (Fischer and Weissmann, unpublished data). More interestingly,
introduction of hamster PrP transgenes into Prn-p°/0 mice rendered
them very susceptible to hamster-derived prions (56 ± 3 days incubation
time) but much less so (303 ±19 days) to mouse-derived prions, demon-
strating the requirement of a homotypic relationship between incoming
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prion and resident PrP protein for prion propagation and development
of pathology, as foreshadowed by the results of Prusiner et al.45
IMPLICATIONS AND OUTLOOK
Both the biochemical and genetic data discussed in this review support
the proposal that the prion is composed partly or entirely of a PrP
isoform (either PrPSc or a subfraction of it), and that protein-encoding
nucleic acid is not an essential component. Other explanations of the
data, such as that PrPC is or contributes to a receptor for the scrapie
agent, while less likely, are not yet formally excluded.
How is PrPC converted to PrPSc?
No chemical differences between PrPC and PrPSc have been detected,
however, as pointed out above, the ratio of infectious units to PrPSc
molecules is about l:105. Therefore, chemical analyses may not bear
on the structure of a conjectural minor component responsible for the
infectivity. Nonetheless, this minor component is likely PrPC-derived,
as indicated by the genetic evidence, and is as resistant to proteinase
digestion as PrPSc.80
Prusiner postulated that the difference between Prpc and PrpSc is
conformational. In Figure 4A it is suggested that a molecule of PrPSc
binds to PrPC and thereby imposes its conformation upon it. The species
barrier is explained by the assumption that heterologous PrP species
interact poorly and/or that the conversion only occurs rarely. Mutations
of the Gerstmann-Straussler and CJD type would allow spontaneous,
albeit very rare conversion events, yielding PrPSc that can then act
catalytically (Fig. 4B). Sporadic cases of CJD could be attributed to
even rarer cases of spontaneous conversion of wild type PrPC or of a
somatically mutated PrPC.
It has so far not been possible to denature infectious preparations
containing PrpSc and renature them to regain infectivity and/or protease
resistance81 contrary to previous reports,82-83 nor has it been possible to
convert PrPC into PrPSc in a cell free system.84 In addition, Prpc does
not, or only in the rarest of cases, spontaneously convert to PrPSc in
vivo, despite the inordinate stability of PrPSc. To explain these findings
within the framework of the 'protein only' model, Figure 4C suggests
that the PrPSc state is separated from that of PrPC and of a random coil
by very high activation energy barriers, while the PrP state is separated
from the random coil state by a far lower barrier. Thus, the only way
PrPC can convert to PrPSc is by 'tunnelling' through the activation
energy barrier by a catalyzed, probably energy-dependent process which
might involve chaperonins.
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Fig. 4 Model for the catalyzed conformational conversion of PrPC to an infectious PrP
form. (A) Following a proposal by Prusiner45 PrPC (C) is converted to the conformer
PrPSc (S) via dimers formed with exogenously introduced PrPSc. This results in an
exponential cascade of conversion. Sporadic forms of prion disease (such as sporadic
CJD) may come about when an extremely rare event (w) leads to spontaneous conversion
of PrPC to PrPSc and gives rise to a conversion cascade. (B) In the case of certain
mutations in PrPC (C+) spontaneous conversion (m) to PrPSc may occur about a million
times more frequently than in the case of the wild type protein, but still remains a
rare event, explaining why familial forms of prion diseases arise only late in life. (C)
Postulated energy diagram for different forms of PrP. The PrPC conformation (C) is
separated from the PrPSc conformation (S) by a high activation energy barrier, and
from the denatured state (D) by a low activation energy barrier. Thus a spontaneous
conformational change from PrPC to PrPSc (pathway w) will be extremely rare. Interaction
of PrPC with PrPSc facilitates the conversion (pathway c) by lowering the activation
energy for the transition. In the case of certain mutations in PrPC the activation energy
for the conversion (pathway m) is lowered, increasing the probability of the spontaneous
conformational change to S
Scrapie strains
As mentioned above, the rinding that there are many distinct strains
of scrapie prions which can be propagated in one and the same mouse
strain (homozygous with regard to its PrP gene) is not readily explained
by the 'protein only' hypothesis (for a review, see Ref 23) because it
implies that an incoming PrPSc strain can convert one and the same
PrP precursor into a likeness of itself, and that this can happen for
several if not many different strains. Two subsidiary hypotheses have
been suggested to circumvent this difficulty. The 'unified theory'85 pro-
poses that PrPSc is associated with a small host-derived nucleic acid
which is not required for infectivity but determines the characteristic
phenotype of the strain. This nucleic acid would be replicated by host
cell enzymes and then associate with newly formed PrPSc leading to
preservation of the prion's phenotype. The 'targeting theory'86 (and
KH Meyer, personal communication 1991) proposes that PrPSc carries a
variable modification, for example carbohydrate residues, which target
it to a specific subset of cells. These cells would impart the same mod-
ification to the newly formed PrPSc molecules. Different strains would
thus be targeted to different subsets of cells and retain their specific
modification (Fig. 5). This hypothesis is supported by the observation
that different hamster prion strains86 or mouse prion strains87 give rise
to different patterns of PrPSc deposition in the brain. It predicts that if
two different prion strains are propagated through a singular cellular
species they should emerge with identical properties.
PRACTICAL IMPLICATIONS OF PRION RESEARCH
The results of Biieler et al25-71 show that it is possible to generate nor-
mal mice which are resistant to scrapie by knocking out their PrP genes.
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Fig. 5 The 'targeting model' to explain prion strain specificity. It is assumed that strain
specificity of the prion is imparted by a cell specific post-translational modification which
targets the prion to the same type of cell as the one in which it was synthesized. A possible
modification would be glycosylation.
In principle it should thus be possible to breed sheep or cattle resistant
to this disease, either by PrP gene disruption or by the introduction
of transgenes expressing PrP antisense RNA. Moreover, the fact that
Prn-p°/+ heterozygous mice show much longer scrapie incubation times
than their wild type counterparts argues that disease progression may
be rate-limited by the PrPC concentration. This conclusion is consistent
with the observation that in several mouse lines containing hamster PrP
transgenes the incubation time for hamster prion-induced scrapie is a
function of the hamster PrP expression level.45 A practical implication
of this conclusion is that a moderate reduction of PrPC synthesis, such
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as might eventually be achieved by antisense oligonucleotide therapy,
could substantially mitigate disease progression in incipient cases of
spongiform encephalopathies.
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